Sentences with phrase «from clinical studies of»

Humphrey takes her inspiration not only from embroidery, but also from clinical studies of the human brain.

To date, results from clinical studies of gene therapies pioneered at St. Jude have been promising.

The FDA authorized marketing the Brain Trauma Indicator after examining data from a clinical study of nearly 2,000 blood samples from patients with suspected concussions.

Not exact matches

Shorn of human weaknesses like the need to eat or sleep, computers are now speed - reading through not only the vast academic literature but also CT scans, electronic medical records, and mountains of data from clinical trials and genomic studies.

(Volunteers with any sort of clinical anxiety issue were excluded from the study.)

Many people believe that eating early in the morning will jumpstart your metabolism or that eating late at night will widen your waist because it's already asleep, but this study from the American Journal of Clinical Nutrition concluded that's a false claim.

Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.

I'm not alone in having a hard time hearing what my gut has to say when I'm already anxious, something a new study published in Clinical Psychological Science supports: researchers from the University of Basel and the Berlin Psychological University found that anxiety may impair your ability to listen to your intuition.

Working with a third - party clinical testing group, Neba studied 275 children and adolescents ranging in age from 6 to 17 years old, all of whom exhibited signs of attention or behavioral concerns.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

For BTN's 2016 Corporate Travel Index, the 32nd annual, BCD Travel's Advito provided the average hotel and car rental costs paid by BCD corporate clients, BTN collected hotel taxes and surcharges from hotels, and eight New York University School of Professional Studies Advanced Research Seminar students, led by academic chair and clinical assistant professor Lynn Minnaert, called restaurants in October and November to gather meal prices.

Under the direction of Lynn Minnaert, academic chair and clinical associate professor in the Jonathan M. Tisch Center for Hospitality and Tourism, part of the New York University School of Professional Studies, eight students called restaurants in 200 cities from January 2018 to February 2018 to gather meal prices.

Utilizing proceeds from the financing, IDEAYA will advance its pipeline with a goal of initiating multiple clinical studies in 2019.

George Budwell (Trevena): The clinical - stage biotech Trevena is set to release top - line results from two phase 3 studies (APOLLO - 1 and APOLLO - 2) for its lead drug candidate, oliceridine, in the first quarter of 2017.

(This is one area in which the cultural narcissists studied in this book may differ from people with some forms of clinical narcissistic personality disorder.

Sad news from the halls of research today, in which a study published in the American Journal of Clinical Nutrition says that eating fried potatoes two or more times a week can double your risk of early death.

Mar. 18, 2013 — People suffering from complicated grief may have difficulty recalling specific events from their past or imagining specific events in the future, but not when those events involve the partner they lost, according to a new study published in Clinical Psychological Science, a journal of the Association for Psychological Science.

A study done in 2000 by the American Journal of Clinical Nutrition indicates that up to 39 % of the population are possibly suffering from Vitamin B12 deficiency.

Using data from clinical food challenge studies, the VSEP has identified reference doses for the common food allergens at which 95 - 99 % of the allergic population are unlikely react (1,2).

Among 11 study participants for whom data from the oral food challenge were either inconclusive or not available, a diagnostic algorithm based on clinical history, the results of a skin - prick test, and the values for peanut - specific IgE were used to determine whether or not a participant should be considered to have peanut allergy (Fig.

Through a rigorous pharmaceutical approach, Gnosis carries out a seamless flow of operations, from product concept to research and development, preclinical and clinical studies, regulatory filing and Intellectual properties, manufacturing and distribution standing alongside customers.

Two earlier peer - reviewed studies published in the American Journal of Clinical Nutrition by researchers from the University of North Carolina in 2012 and 2013 randomly assigned non-dieting participants to drink either water or diet beverages.

The 12 week clinical study from the US of 303 participants is the first prospective, randomised clinical trial to directly compare the effects of water and diet beverages on weight loss within a behavioural weight loss program.

In 2010, researchers from the University of Michigan Comprehensive Cancer Center published a study in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cells.

Replacing refined grains with whole grains may help prevent fat from accumulating around your belly, reports a Pennsylvania State University study in the «American Journal of Clinical Nutrition» in 2008.

Despite finding that underreporting continues to be what she wrote in two 2013 studies to be an «alarming» [17] and «overwhelming» problem, [16] Johna Register - Mihalik, Ph.D, LAT, ATC, Senior Research Associate at WakeMed and Adjunct Assistant Professor at UNC - Chapel Hill, told MomsTEAM that the the reason the use of impact sensors was not among the recommendations she and her co-authors in those studies made to address the problem of chronic underreporting was that she viewed «the use of impact sensors in concussion detection, as the science, although a growing field of information, is just not quite there in how these may best be used from a clinical standpoint and across all sport settings.»

Despite finding that underreporting continues to be what she wrote in two 2013 studies to be an «alarming» and «overwhelming» problem, Dr. Johna Register - Mihalik, a research scientist and member of the faculty at the Matthew Gfeller Sport - Related TBI Research Center at the University of North Carolina at Chapel Hill, recently told MomsTEAM that the reason she and her colleagues did not recommend the use of impact sensors in addressing the problem was that she viewed «the use of impact sensors in concussion detection, as the science, although a growing field of information, [as] just not quite there in [terms of] how the [y] may best be used from a clinical standpoint and across all sport settings.»

Dr. Eastwood has an undergraduate degree in Human Biology from Stanford University, and a doctorate in clinical psychology from the California Institute of Integral Studies.

Much of the evidence against BPA comes from large population studies rather than controlled clinical trials.

Using DTI, researchers at Wake Forest found in a 2014 study [26] that a single season of high school football can produce changes in the white matter of the brain of the type previously associated with mTBI in the absence of a clinical diagnosis of concussion, and that these impact - related changes in the brain are strongly associated with a postseason change in the verbal memory composite score from baseline on the ImPACT neurocognitive test.

The collaborative study was developed from a meeting last August of sports medicine clinicians, researchers and a bioethicist to understand the current evidence risks and rewards and future directions of research and clinical practice for regenerative medicine therapies in youth sports.

Interestingly, emotional eating is a learned behavior, according to a study in The American Journal of Clinical Nutrition, so there are things parents can do to prevent emotional eating from taking hold.

There has been concern raised about a resurgence of vitamin D deficiency and rickets among infants and children, with reports emerging in the United States from Alaska, 1,2 Iowa, 3 Nevada, 4 California, 5 North Carolina, 6 Texas, 7 and mother - infant pairs in Boston, 8 among others.9 The prevalence of vitamin D deficiency in young children also appears to be high in other countries, including England, 10 Greece, 11 and Canada.12, 13 One study from China found a 65.3 % prevalence of vitamin D deficiency among 12 - to 24 - month - olds, but few cases (3.7 %) of radiographic or clinical rickets were noted.14 Previous studies suggest risk factors to be dark skin pigmentation1,3 - 12 and breastfeeding without supplementation.1 - 7, 9,12,13 To date, reports have focused primarily on young infants compared with toddlers.

If you decide not to take part in a research study or clinical trial, you and your baby will continue to receive the same quality of care from the health care team and the hospital.

While the theoretical principles guiding the use of the NBO and the accompanying training program, include many of the conceptual themes that informed our work with the NBAS, they are influenced by theoretical and clinical principles from the fields of infant mental health, child development, brain development, behavioral pediatrics, systems theory, communication studies, nursing, early intervention and cultural studies, among its influences.

Relatedly, few studies have distinguished elevated depressive symptoms from the clinical condition of major depressive disorder.

Dr. Robert Cantu, one of the world's leading experts on head trauma in sport and a clinical professor of neurosurgery at Boston University School of Medicine, has pointed to studies showing at least 30 percent of concussions in soccer come from the act of heading the ball, sometimes through direct contact with the ball but more significantly when the head smashes into another player or the ground.

The study's lead author, Mr Jason Bentley from the Menzies Centre for Health Policy commented: «There is an urgent need for strategies to inform more judicious clinical decision making about the timing of planned birth.»

Approval for the study was obtained from the University of British Columbia Clinical Research Ethics Board.

Two randomly assigned study groups of expectant mothers were formed over a 7 - month period (12/94 — 6/95) from three independent, obstetric practices in six clinical offices in and around the Greater Rochester, NY, area.

Results from this study were published in the May 12, 2010 issue of the Journal of Allergy and Clinical Immunology.

The initiative was introduced to the United Kingdom in 1993, but, although improvements have been reported, 3 rates of breast feeding in the UK are still among the lowest in the world.4 5 Recent reports from the National Institute for Health and Clinical Excellence (NICE) urge NHS units to become baby friendly to improve rates of breast feeding and save money.4 6 Data from the millennium cohort study, however, show that though participating maternity units in the UK increased rates of initiation of breastfeeding, duration did not increase.5 Other strategies are therefore required to support mothers in the UK to breast feed for the recommended time.

In addition, there was no effect on breastfeeding duration when the pacifier was introduced at 1 month of age.280 A more recent systematic review found that the highest level of evidence (ie, from clinical trials) does not support an adverse relationship between pacifier use and breastfeeding duration or exclusivity.281 The association between shortened duration of breastfeeding and pacifier use in observational studies likely reflects a number of complex factors such as breastfeeding difficulties or intent to wean.281 A large multicenter, randomized controlled trial of 1021 mothers who were highly motivated to breastfeed were assigned to 2 groups: mothers advised to offer a pacifier after 15 days and mothers advised not to offer a pacifier.

Although some SIDS experts and policy - makers endorse pacifier use recommendations that are similar to those of the AAP, 272,273 concerns about possible deleterious effects of pacifier use have prevented others from making a recommendation for pacifier use as a risk reduction strategy.274 Although several observational studies275, — , 277 have found a correlation between pacifiers and reduced breastfeeding duration, the results of well - designed randomized clinical trials indicated that pacifiers do not seem to cause shortened breastfeeding duration for term and preterm infants.278, 279 The authors of 1 study reported a small deleterious effect of early pacifier introduction (2 — 5 days after birth) on exclusive breastfeeding at 1 month of age and on overall breastfeeding duration (defined as any breastfeeding), but early pacifier use did not adversely affect exclusive breastfeeding duration.

She received her undergraduate degree in Human Development and Family Studies from Indiana University in Bloomington, Indiana and her graduate degree in Clinical Mental Health Counseling from Indiana University of Pennsylvania.

Sheila M Innis; Essential fatty acids in infant nutrition: lessons and limitations from animal studies in relation to studies on infant fatty acid requirements, The American Journal of Clinical Nutrition, Volume 71, Issue 1, 1 January 2000, Pages 238S — 244S, https://doi.org/10.1093/ajcn/71.1.238S

The bill would make it mandatory for researchers to publish all information from cancer clinical trials, with the goal being to get more researchers to work together and bring down the number of duplicative studies.

Since the neuronal death can be recapitulated in directly reprogrammed patient neurons, Yoo said the new technique offers a way to study the details of how potential therapies — including drugs that are currently being tested in clinical trials — could rescue medium spiny neurons from death.

However, those guidelines from 2011 predate more recent clinical studies of HPV testing that were analyzed in today's paper.

The study by Alison McLeish, a University of Cincinnati associate professor of psychology, Christina Luberto, a recent doctoral graduate from UC and clinical fellow at Massachusetts General Hospital, and Emily O'Bryan, a graduate student in the UC Department of Psychology, will be presented at the Association for Behavioral and Cognitive Therapies (ABCT) 49th Annual Convention.